- Title
- The acceptability and feasibility of implementing a fractional exhaled nitric oxide (FeNO)-based asthma management strategy into antenatal care: the perspective of pregnant women with asthma
- Creator
- McLaughlin, Karen; Jensen, Megan E.; Foureur, Maralyn; Gibson, Peter; Murphy, Vanessa E.
- Relation
- NHMRC.1060983 http://purl.org/au-research/grants/nhmrc/1060983
- Relation
- Midwifery Vol. 88, Issue September 2020, no. 102757
- Publisher Link
- http://dx.doi.org/10.1016/j.midw.2020.102757
- Publisher
- Churchill Livingstone
- Resource Type
- journal article
- Date
- 2020
- Description
- The prevalence of asthma in pregnancy has increased in the US from 5.5% in 2001 to 7.8% in 2007 (Hansen et al., 2013 ) with the most recently reported prevalence in 2019 of 9.1% (Cohen et al., 2019 ). Sweden has a prevalence of 9.4% (Reino et al., 2014 ). In Australia, asthma is the most common chronic condition during pregnancy, complicating 12.7% of pregnancies (Sawicki et al., 2012 ). The increased risk of adverse maternal (gestational diabetes [RR 1.39, 95% CI 1.17, 1.66]; hypertension and pre-eclampsia [RR 1.54, 95% CI 1.32-1.81]) and fetal outcomes (low birth weight [RR 1.46, 95% CI 1.22-1.75]; premature birth [RR 1.41, 95% CI 1.22-1.61]) with maternal asthma is well documented (Murphy et al., 2011 ; Namazy et al., 2012 ; Murphy et al., 2013 ; Wang et al., 2014 ). Adverse outcomes are further increased if the woman experiences exacerbation of her asthma symptoms during pregnancy (Namazy et al., 2013 ; Wang et al., 2014 ). Thus, optimising asthma control and minimising exacerbations is the goal of antenatal asthma management.
- Subject
- asthma; pregnant women; antenatal care; asthma medications; SDG 3; Sustainable Development Goals
- Identifier
- http://hdl.handle.net/1959.13/1451424
- Identifier
- uon:44185
- Identifier
- ISSN:0266-6138
- Language
- eng
- Reviewed
- Hits: 499
- Visitors: 499
- Downloads: 0
| Thumbnail | File | Description | Size | Format |
|---|